Exchange: NYSE
Industry: Health Care Equipment & Services
Last Trade: 4:00 PM ET 4/5/2013
Last 10 Quotes:
What's This?
| Fiscal Q4 Ending 12/12 |
Fiscal Q3 Ending 09/12 |
Fiscal Q2 Ending 06/12 |
Fiscal Q1 Ending 03/12 |
Fiscal Q4 Ending 12/11 |
|
Sales/Revenue |
699,748 | 696,482 | 690,810 | 683,525 | 671,971 |
Cost of Goods Sold (COGS) incl. D&A |
561,837 | 557,551 | 548,000 | 541,308 | 532,019 |
COGS excluding D&A |
494,858 | 490,132 | 479,853 | 473,491 | 465,540 |
Depreciation & Amortization Expense |
66,979 | 67,419 | 68,147 | 67,817 | 66,479 |
Gross Income |
137,911 | 138,931 | 142,810 | 142,217 | 139,952 |
SG&A Expense |
44,627 | 43,158 | 46,071 | 44,973 | 28,004 |
Research & Development |
0 | 0 | 0 | 0 | 0 |
Other SG&A |
44,627 | 43,158 | 46,071 | 44,973 | 28,004 |
Other Operating Expense |
70,785 | 71,167 | 70,628 | 71,445 | 80,526 |
Unusual Expense |
10,537 | -140 | 7,524 | -607 | 11,337 |
Non Operating Income/Expense |
201 | 500 | 3 | -111 | 765 |
Equity in Affiliates (Pretax) |
-3,277 | -249 | -61 | 99 | 0 |
Interest Expense |
36,074 | 36,805 | 37,017 | 36,523 | 36,609 |
Gross Interest Expense |
36,074 | 36,805 | 37,017 | 36,523 | 36,609 |
Pretax Income |
-25,396 | -11,132 | -17,796 | -9,277 | -15,759 |
Income Tax |
-909 | 878 | 1,014 | 1,061 | 253 |
Equity in Affiliates |
0 | 0 | 0 | 0 | 1,137 |
Consolidated Net Income |
-24,487 | -12,010 | -18,810 | -10,338 | -14,875 |
Minority Interest Expense |
0 | 0 | 0 | 0 | 0 |
Net Income |
-24,487 | -12,010 | -18,810 | -10,338 | -14,875 |
Extraordinaries & Discontinued Operations |
0 | 0 | 0 | 0 | 0 |
Extra Items & Gain/Loss Sale Of Assets |
0 | 0 | 0 | 0 | 0 |
Cumulative Effect - Accounting Chg |
0 | 0 | 0 | 0 | 0 |
Discontinued Operations |
0 | 0 | NA | NA | 0 |
Net Income After Extraordinaries |
-24,487 | -12,010 | -18,810 | -10,338 | -14,875 |
Preferred Dividends |
0 | 0 | 0 | 0 | 0 |
Net Income available to Common |
-24,487 | -12,010 | -18,810 | -10,338 | -14,875 |
Operational EPS |
-0.14 | -0.10 | -0.11 | -0.09 | -0.06 |
EPS (basic) |
-0.20 | -0.10 | -0.15 | -0.09 | -0.12 |
EBITDA |
89,478 | 92,025 | 94,258 | 93,616 | 97,901 |
Depreciation & Amortization Expense |
66,979 | 67,419 | 68,147 | 67,817 | 66,479 |
Common Shares Outstanding |
122,608 | 122,493 | 121,708 | 121,145 | 121,161 |
Basic Shares Outstanding |
122,608 | 122,493 | 121,708 | 121,145 | 121,161 |
Diluted Shares Outstanding |
122,608 | 122,493 | 121,708 | 121,145 | 121,161 |
Diluted EPS after Extraordinary Items |
-0.20 | -0.10 | -0.15 | -0.09 | -0.12 |
Discont. Operations Per Share |
0 | 0 | 0 | 0 | 0 |
Continued operations EPS |
-0.20 | -0.10 | -0.15 | -0.09 | -0.12 |
*Figures in thousands of U.S. Dollars except shares outstanding.
